. 2015 Mar 20;34(13):2081–2103. doi: 10.1002/sim.6471

Table 4.

Results of the internal–external cross‐validation procedure for the temperature data.

Study	Observed no. with fever (O)	Observed prevalence	Summary prevalence from meta‐analysis model (8), ^∗	Summary sensitivity from meta‐analysis model (1), ^∗	Summary specificity from meta‐analysis model (1), ^∗	Option A Post‐test predictions obtained using summary sensitivity, summary specificity and summary prevalence (Equations (6) and (7))				Option B Post‐test predictions obtained using summary sensitivity, summary specificity and observed prevalence (Equations (9) and (10))				Option C Post‐test predictions obtained after bivariate meta‐regression of PPV and NPV on prevalence (Equations (12) and (13))
Study	Observed no. with fever (O)	Observed prevalence	Summary prevalence from meta‐analysis model (8), ^∗	Summary sensitivity from meta‐analysis model (1), ^∗	Summary specificity from meta‐analysis model (1), ^∗	Predicted PPV	Predicted NPV	Expected no. with fever ^{^} (E)	O/E	Predicted PPV	Predicted NPV	Expected no. with fever ^{^} (E)	O/E	Predicted PPV	Predicted NPV	Expected no. with fever ^{^}(E)	O/E
Brennan	203	0.55	0.45	0.644	0.99	0.97	0.77	207.59	0.98	0.98	0.69	226.11	0.90	0.98	0.75	211.83	0.96
Davis	18	0.27	0.48	0.661	0.98	0.97	0.76	24.41	0.74	0.94	0.89	16.85	1.07	0.96	0.78	22.71	0.79
Green	9	0.43	0.46	0.631	0.98	0.97	0.76	10.92	0.82	0.97	0.78	10.58	0.85	0.96	0.76	10.80	0.83
Greenes	109	0.36	0.46	0.67	0.98	0.97	0.77	110.91	0.98	0.96	0.83	94.12	1.16	0.95	0.78	106.11	1.03
Hoffman	42	0.42	0.47	0.645	0.99	0.97	0.77	47.23	0.89	0.96	0.80	44.56	0.94	0.97	0.76	47.06	0.89
Hooker	15	0.38	0.46	0.65	0.98	0.97	0.76	16.63	0.90	0.96	0.82	14.97	1.00	0.96	0.78	16.07	0.93
Lanham	103	0.58	0.47	0.666	0.98	0.97	0.76	81.98	1.26	0.98	0.67	94.01	1.10	0.98	0.76	82.71	1.25
Muma	87	0.39	0.46	0.662	0.98	0.97	0.78	84.73	1.03	0.96	0.83	75.98	1.15	0.95	0.78	84.66	1.03
Nypaver	425	0.48	0.45	0.652	0.98	0.97	0.78	408.91	1.04	0.97	0.76	426.06	1.00	0.97	0.76	421.87	1.01
Rhoads	27	0.42	0.47	0.683	0.98	0.96	0.77	20.25	1.33	0.96	0.80	18.12	1.49	0.96	0.77	19.78	1.36
Stewart	59	0.75	0.43	0.65	0.98	0.97	0.78	59.88	0.99	0.99	0.49	67.79	0.87	0.98	0.56	65.61	0.90

^∗

Obtained from meta‐an the study in the row.

^{^}

Expected number for the study in the row, based on using Equation (14) and the positive predictive value (PPV) and negative predictive value (NPV) in the prior two columns.